ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Cancer

Acute Myeloid Leukemia (AML) trials near Budapest, Budapest, HUN:

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

when co administered with low-dose cytarabine (LDAC) improves overall survival (OS) versus LDAC and placebo, in treatment-naïve patients with acute...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Budapest, Hungary and 108 other locations

A study of siremadlin in combination with venetoclax plus azacitidine in adult participants with AML who are ineligible for chemotherapy.The...

Active, not recruiting
Acute Myeloid Leukemia
Drug: siremadlin
Drug: venetoclax

Phase 1

Novartis
Novartis

Budapest, Hungary and 9 other locations

This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: CC-486
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Budapest, Hungary and 157 other locations

Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Budapest, Hungary and 171 other locations

available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...

Active, not recruiting
Acute Myeloid Leukemia
Biological: Galinpepimut-S
Drug: Azacitidine

Phase 3

Sellas Life Sciences

Budapest, Hungary and 72 other locations

Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Azacitidine
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Szekesfehervar, Fejer, Hungary and 221 other locations

This is a long term safety study for patients that have been treated with either ruxolitinib or a combination of ruxolitinib with panobinostat, on a...

Enrolling
Acute Myeloid Leukemia
Graft Versus Host Disease
Drug: panobinostat
Drug: ruxolitinib

Phase 4

Novartis
Novartis

Budapest, Hungary and 96 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems